[在受感染的伤口中使用局部止血药]
V O Tsvetkov1, O V Kolovanova2, E E Goloshchapova1
1Sechenov University, Moscow, Russia.
Khirurgiia
|November 25, 2025
概括
局部静血剂,包括原海绵和氧化再生纤维素,有效控制受感染伤口的手术出血. 这些药物并没有对术后伤口并发症率产生负面影响.
科学领域:
- 手术方面的创新.
- 伤口管理 伤口管理
- 在外科手术中的生物材料.
背景情况:
- 局部静血剂是手术出血的标准,但它们在受感染的伤口中的有效性需要进一步调查.
- 这项研究评估了受感染的手术伤口中的原体海绵和氧化再生纤维素.
研究的目的:
- 评估原体海绵和氧化再生纤维素在控制受感染伤口外科手术出血方面的有效性.
- 确定这些局部静血剂对手术后伤口并发症的影响.
主要方法:
- 对32名接受手术关闭受感染伤口的患者的回顾性分析.
- 当手术方法不足时,应用原体海绵 (22例) 或氧化再生纤维素 (10例) 来控制出血.
主要成果:
- 原体海绵和氧化再生纤维素都证明了对手术出血的强有力的控制.
- 没有观察到局部静血剂对术后伤口并发症的发生率或类型的可见影响.
结论:
- 原海绵和氧化再生纤维素是感染手术伤口的有效静血剂.
- 使用这些局部止血药似乎不会增加伤口并发症的风险.
相关概念视频
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
1.1K
Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
One of the advantages of...
1.1K
Introduction to Hemostasis
13.1K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
13.1K
Local Anesthetics: Pharmacokinetics
1.2K
The potency and duration of action of local anesthetics (LAs) are determined by their pharmacokinetics. Pharmacokinetics describes how LAs are absorbed, distributed, metabolized, and eliminated from the body. When administered to the vascular tissues, LAs are quickly absorbed and enter the systemic circulation, reducing their localized effects. Adding vasoconstrictors such as epinephrine to LAs reduces their absorption into the systemic circulation, making them clinically effective. The...
1.2K
Local Anesthetics: Clinical Application as Surface, Infiltration, and Conduction Block Anesthesia
1.8K
Depending on the target organ, local anesthetics (LAs) can be administered via various routes. In surface anesthesia, LAs are applied directly to the surface of the skin or mucous membranes. It is widely used for topical skin numbing before venipuncture or minor surgical procedures. Commonly used surface local anesthetics are lidocaine or benzocaine sprays or creams. Surface anesthesia occurs within 5 minutes and lasts for about 60 minutes. One of the main disadvantages of topical anesthesia is...
1.8K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Extrinsic and Intrinsic Pathways of Hemostasis
11.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.9K


